BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 19875089)

  • 1. Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis.
    Bang S; Edell E; Eghrari AO; Gottsch JD
    Am J Ophthalmol; 2010 Jan; 149(1):66-9. PubMed ID: 19875089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acanthamoeba keratitis associated with contact lens wear in Singapore.
    Por YM; Mehta JS; Chua JL; Koh TH; Khor WB; Fong AC; Lim JW; Heng WJ; Loh RS; Lim L; Tan DT
    Am J Ophthalmol; 2009 Jul; 148(1):7-12.e2. PubMed ID: 19403109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral Acanthamoeba keratitis in an experienced two-weekly disposable contact lens wearer.
    Voyatzis G; McElvanney A
    Eye Contact Lens; 2007 Jul; 33(4):201-2. PubMed ID: 17630630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of topical corticosteroids in the management of Acanthamoeba keratitis.
    Park DH; Palay DA; Daya SM; Stulting RD; Krachmer JH; Holland EJ
    Cornea; 1997 May; 16(3):277-83. PubMed ID: 9143798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral Acanthamoeba keratitis in Synergeyes contact lens wear: clinical and confocal microscopy findings.
    Lee WB; Gotay A
    Eye Contact Lens; 2010 May; 36(3):164-9. PubMed ID: 20386314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical experience of Acanthamoeba keratitis at a tertiary care eye hospital.
    Tanhehco T; Colby K
    Cornea; 2010 Sep; 29(9):1005-10. PubMed ID: 20539211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acanthamoeba keratitis with chlorhexidine.
    Kosrirukvongs P; Wanachiwanawin D; Visvesvara GS
    Ophthalmology; 1999 Apr; 106(4):798-802. PubMed ID: 10201605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratoplasty for treatment of Acanthamoeba keratitis.
    Kitzmann AS; Goins KM; Sutphin JE; Wagoner MD
    Ophthalmology; 2009 May; 116(5):864-9. PubMed ID: 19410943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acanthamoeba keratitis: persistent organisms without inflammation after 1 year of topical chlorhexidine.
    Gooi P; Lee-Wing M; Brownstein S; El-Defrawy S; Jackson WB; Mintsioulis G
    Cornea; 2008 Feb; 27(2):246-8. PubMed ID: 18216589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of real-time polymerase chain reaction in diagnosing and treating acanthamoeba keratitis.
    Itahashi M; Higaki S; Fukuda M; Mishima H; Shimomura Y
    Cornea; 2011 Nov; 30(11):1233-7. PubMed ID: 21955634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of chronic stromal acanthamoeba keratitis with oral voriconazole monotherapy.
    Tu EY; Joslin CE; Shoff ME
    Cornea; 2010 Sep; 29(9):1066-8. PubMed ID: 20539217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical Voriconazole as Supplemental Treatment for Acanthamoeba Keratitis.
    Musayeva A; Riedl JC; Schuster AK; Wasielica-Poslednik J; Pfeiffer N; Gericke A
    Cornea; 2020 Aug; 39(8):986-990. PubMed ID: 32243421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acanthamoeba keratitis: clinical characteristics and management.
    Sun X; Zhang Y; Li R; Wang Z; Luo S; Gao M; Deng S; Chen W; Jin X
    Ophthalmology; 2006 Mar; 113(3):412-6. PubMed ID: 16427699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acanthamoeba keratitis in a 5-year-old boy without a history of contact lens usage.
    Demirci G; Ay GM; Karabas LV; Altintas O; Tamer GS; Cağlar Y
    Cornea; 2006 Apr; 25(3):356-8. PubMed ID: 16633040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine.
    Seal D; Hay J; Kirkness C; Morrell A; Booth A; Tullo A; Ridgway A; Armstrong M
    Eye (Lond); 1996; 10 ( Pt 4)():413-21. PubMed ID: 8944089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetrating keratoplasty in active Acanthamoeba keratitis.
    Nguyen TH; Weisenthal RW; Florakis GJ; Reidy JJ; Gaster RN; Tom D
    Cornea; 2010 Sep; 29(9):1000-4. PubMed ID: 20520535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors associated with the need for surgical treatments in acanthamoeba keratitis.
    Bouheraoua N; Gaujoux T; Goldschmidt P; Chaumeil C; Laroche L; Borderie VM
    Cornea; 2013 Feb; 32(2):130-6. PubMed ID: 23132441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis.
    Robaei D; Carnt N; Minassian DC; Dart JK
    Ophthalmology; 2014 Jul; 121(7):1383-8. PubMed ID: 24630688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of Acanthamoeba keratitis in contact lens wearers and non-wearers.
    Wanachiwanawin D; Booranapong W; Kosrirukvongs P
    Southeast Asian J Trop Med Public Health; 2012 May; 43(3):549-56. PubMed ID: 23077833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical and oral voriconazole in the treatment of fungal keratitis.
    Bunya VY; Hammersmith KM; Rapuano CJ; Ayres BD; Cohen EJ
    Am J Ophthalmol; 2007 Jan; 143(1):151-3. PubMed ID: 17188052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.